Market
What will be the outcome of the VA MDMA therapy study for PTSD and alcohol use disorder?
2
Resolution / Starting Odds
Significant positive impact • 25%
Moderate positive impact • 25%
No significant impact • 25%
Negative impact • 25%
Official study results published by the U.S. Department of Veterans Affairs
Story
VA Funds $1.5M Study on MDMA Therapy for Veterans with PTSD and Alcohol Use Disorder
Dec 3, 2024, 05:54 PM
The U.S. Department of Veterans Affairs (VA) has announced its first study on psychedelic-assisted therapy since the 1960s, focusing on the potential of MDMA-assisted therapy to treat post-traumatic stress disorder (PTSD) and alcohol use disorder among veterans. The study, funded with $1.5 million, is a significant step towards exploring alternative treatments for conditions that disproportionately affect veterans. This initiative marks a notable shift in policy, as it is the first VA-funded study on psychedelics in over five decades, highlighting a growing interest in the therapeutic potential of psychedelics for mental health issues.
View original story
Similar markets
Not effective for either condition • 25%
Effective only for PTSD • 25%
Effective only for alcohol use disorder • 25%
Effective for both PTSD and alcohol use disorder • 25%
Significant positive results • 25%
Moderate positive results • 25%
No significant results • 25%
Negative results • 25%
Anxiety • 25%
Depression • 25%
PTSD • 25%
Substance use disorders • 25%
No significant change in alcohol intake • 25%
Increase in alcohol intake • 25%
Significant reduction in alcohol intake • 25%
Moderate reduction in alcohol intake • 25%
Inconclusive results • 34%
Successful trial • 33%
Unsuccessful trial • 33%
No • 50%
Yes • 50%
Significant improvement • 25%
Worsening condition • 25%
No improvement • 25%
Moderate improvement • 25%